ZBIO compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name

ZBIOZenas BioPharma, Inc.

Mkt capRevenueRevenue

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ZBIOZenas BioPharma, Inc.

MBXMBX Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ZBIO 10

BMYBristol-Myers Squibbcustomer

XNCRXencorsupplier

—InnoCareunlistedsupplier

—WuXi Biologicsunlistedsupplier

6 more · ZBIO chain ›

Shared 0

No shared counterparties.

Only MBX 3

—Dr. Richard DiMarchiunlistedsupplier

—Indiana University Research and Technology Corporation ("IURTC")unlistedsupplier

—Trustees of Indiana Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ZBIOZenas BioPharma, Inc.

28.28▲+9.07%· post 28.28

Mkt cap$1.9BRevenue$10MQ3 FY26

MBXMBX Biosciences, Inc.

51.17▲+5.59%· post 51.17

ClosedNov 6 '26

Mkt cap$2.4BRevenue—

Compare

ClosedNov 6 '26

ZBIOZenas BioPharma, Inc.

MBXMBX Biosciences, Inc.

28.28▲+9.07%post 28.28

Price

51.17▲+5.59%post 51.17

$1.9B

Mkt cap

$2.4B

Q3 FY26$10M

Revenue

—

ZBIO28.28▲+9.07%vsMBX51.17▲+5.59%ClosedNov 6 '26